Elsayed Soliman to Diabetic Neuropathies
This is a "connection" page, showing publications Elsayed Soliman has written about Diabetic Neuropathies.
Connection Strength
0.849
-
Pop-Busui R, Rosin SP, Butera NM, Krause-Steinrauf H, Abou Assi H, Garg RK, Inzucchi SE, Katona A, McGill JB, Mudaliar S, Schade DS, Seaquist ER, Tiktin M, Soliman EZ, Green JB. Differences in Prevalence and Incidence of Electrocardiogram Abnormalities and Cardiovascular Autonomic Neuropathy Among Randomized Glucose-Lowering Treatments in Early Type 2 Diabetes: The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort. Diabetes Care. 2025 Nov 01; 48(11):1960-1970.
Score: 0.232
-
Braffett BH, El Ghormli L, Martin C, White NH, Hirsch IB, Bantle A, Carlson A, Leschek E, Gubitosi-Klug R, Soliman EZ, Vella A, Perkins BA, Bebu I, Pop-Busui R. Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes. Cardiovasc Diabetol. 2025 Aug 13; 24(1):334.
Score: 0.228
-
Rooney MR, Norby FL, Soliman EZ, Chen LY, Selvin E, Echouffo-Tcheugui JB. Duration of diabetes, glycemic control, and low heart rate variability: The Atherosclerosis Risk in Communities (ARIC) study. J Diabetes Complications. 2024 Dec; 38(12):108903.
Score: 0.216
-
Pop-Busui R, Backlund JC, Bebu I, Braffett BH, Lorenzi G, White NH, Lachin JM, Soliman EZ. Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type?1 diabetes patients. J Diabetes Investig. 2022 Jan; 13(1):125-133.
Score: 0.173